Biomarin Pharmaceutical Inc (BMRN)
69.51
+1.35
(+1.98%)
USD |
NASDAQ |
Oct 04, 16:00
69.50
-0.01
(-0.01%)
Pre-Market: 20:00
Biomarin Pharmaceutical Shareholders Equity (Annual): 4.952B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.952B |
| December 31, 2022 | 4.603B |
| December 31, 2021 | 4.266B |
| December 31, 2020 | 4.106B |
| December 31, 2019 | 3.122B |
| December 31, 2018 | 2.968B |
| December 31, 2017 | 2.809B |
| December 31, 2016 | 2.766B |
| December 31, 2015 | 2.401B |
| December 31, 2014 | 1.528B |
| December 31, 2013 | 1.341B |
| December 31, 2012 | 1.016B |
| December 31, 2011 | 773.05M |
| Date | Value |
|---|---|
| December 31, 2010 | 717.26M |
| December 31, 2009 | 322.18M |
| December 31, 2008 | 276.68M |
| December 31, 2007 | 187.73M |
| December 31, 2006 | 117.80M |
| December 31, 2005 | -77.46M |
| December 31, 2004 | -67.98M |
| December 31, 2003 | 117.85M |
| December 31, 2002 | 98.54M |
| December 31, 2001 | 159.55M |
| December 31, 2000 | 69.99M |
| December 31, 1999 | 98.38M |
| December 31, 1998 | 29.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
3.122B
Minimum
2019
4.952B
Maximum
2023
4.210B
Average
4.266B
Median
2021
Shareholders Equity (Annual) Benchmarks
| Bristol-Myers Squibb Co | 29.43B |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Merck & Co Inc | 37.58B |
| Repligen Corp | 1.971B |
| Bioventus Inc | 173.59M |